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ABSTRACT 
The present study was undertaken to formulate and evaluate the anti-inflammatory, anti-oxidant and anti-angiogenic activities of 
nanoemulsion of Memecylaene.  Memecylaene was isolated from the leaves of Memecylon malabaricum by using various 
chromatographic methods. An oil-in-water (O/W) nanoemulsion of Memecylaene was formulated by sonication method using 
sunflower oil (oil phase), Tween 80 (Surfactant) and Ethanol (co-surfactant). The prepared nanoemulsion was characterized for its 
droplet size, poly dispersity index and zeta potential. Stability studies were performed and the nanoemulsions were subjected to 
different biological activities. The formulated nanoemulsion had a particle size range of 52.02 nm to 59.47 nm and zeta potential of -
1.27 mV. The enhanced activity of Memecylaene, encapsulated in O/W emulsions is evidenced by the inhibition of phospholipase 
(PLA2) enzyme and H+, K+ -ATPase and thus showing anti-inflammatory and anti-secretagogues effects. The in vitro anti-oxidant 
activity was evaluated by DPPH radical and Nitric oxide radical scavenging activity. Further, the inhibition of the growth of neo 
vessels formation in the in-vivo model system of chick chorioallantoic membrane (CAM) assay, which is angiogenesis dependent, 
was also observed. The above findings would help in understanding the putative potential of Memecylaene-loaded nanoemulsion as a 
therapeutic agent. 
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INTRODUCTION 
Memecylon malabaricum is a medicinal plant 
indigenous to the Western Ghats of India. It is a potent 
plant material containing a number of bioactive 
compounds like steroids, triterpenes, flavonoids, 
saponins, tannins and resins. The leaves are being used 
as a traditional remedy to cure skin diseases, several 
stomach disorders, chicken pox, polyuria, menorrhagia 
and herpes
1
. Memecylaene,4,9,14,19-Tetramethyl-
1,6,11,16-tetraoxacycloeicosa-3,8,13,19-tetraene plays a 
promising role as an anti-angiogenic, anti-proliferative, 
pro-apoptotic, anti-oxidant and anti-inflammatory 
molecule in vivo and ex vivo experiments
2
. The 
molecule showed a unique structure simulating crown 
ethers with promising biological potency. Memecylaene, 
a highly lipophilic compound, exhibits dissolution 
related problem and low absorption; therefore, the 
efficacy may be greatly reduced. Hence, a prospective 
drug delivery system is essential to enhance the 
therapeutic index of Memecylaene, by improving its 
solubilisation property and modifying their 
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pharmacokinetic profiles. Hence, a unique formulation 
to alter its physicochemical characteristics is required. 
The molecule being soluble in sunflower oil to a greater 
extent, a simple nanoemulsion (NE) system was 
formulated with no input of high-energy methods, which 
makes the molecule readily available for transdermal 
injection. 
The design of effective formulations of NE for drugs has 
always been a major challenge due to severely limited 
drug efficacy can be of instability or its hydrophobicity. 
Using nanoparticles (NPs) as drug delivery systems is 
one of the most promising technologies that are being 
applied to improve the solubility and bioavailability of 
hydrophobic drugs. The transport properties of the drug 
would be influenced by the nanosized droplets that lead 
to an enormous increase in interfacial areas that are 
associated with NPs. NEs are unique due to the presence 
of compartmentalized hydrophobic domains in which 
both non-polar and polar compounds could be 
incorporated
3,4
. There are several reports on plant-based 
essential oil-derived NE system that have prospective 
applications in pharmaceuticals
5
. In our current study, a 
biologically acceptable oil-in-water NE system as 
molecule delivery vehicle for Memecylaene to improve 
the efficacy and stability of the drug without the input of 
high energy methods was optimized. This system is 
expected to enable easy transport through the smallest 
capillary vessels without any discrimination by the host 
defence mechanism and thereby, readily absorbed by the 
organs.  
MATERIALS AND METHOD 
Materials 
Memecylon malabaricum leaves, Silica gel for column 
chromatography, Sunflower oil, Tween 80, ethanol, 
Phosphate Buffer Saline, Omeprazole (Ome), Russell 
viper venom, Kreb’s ringer buffer, 2mM HEPES-Tris, 
Sucrose-EDTA buffer, fertilized eggs, Butylated 
hydroxyl toluene (BHT), 1, 1-diphenyl 2-picrylhydrazyl 
(DPPH). 
Methods 
Isolation of Memecylaene 
The leaves of Memecylon malabaricum collected from 
the Western Ghats, Karnataka state, India and identified 
and authenticated by the taxonomist.  They were shade 
dried and coarsely ground.  The ground leaves were 
loaded onto the Soxhlet for extraction, using hexane as 
the solvent system.  The extract was filtered and loaded 
onto the column packed with silica gel (100-200 mesh) 
in chloroform and eluted in chloroform.  The fraction 
collected was precipitated using methanol and filtered. 
Memecylaene was purified from the residue using thin 
layer chromatography. Thus obtained Memecylaene was 
used for the preparation of nanoemulsion. 
Preparation of nanoemulsion 
NE was prepared by the sonication method. 0.1g of 
Memecylaene was dissolved in 0.5mg of sunflower oil 
and was added to 2ml of Smix (1:1.5 ratio of Tween 80: 
Ethanol) in a beaker placed on a magnetic stirrer. Water 
was simultaneously added drop wise and was left to 
form a uniform mixture on the magnetic stirrer for a 
known interval of time.  The whole mixture was made to 
undergo probe sonication for a known interval of time 
and speed. The formulation table of the prepared NE is 
given in Table 1.  
Stability studies of the nanoemulsion 
Four cycles of the heating-cooling cycle between 
refrigerator temperature (4°C) and 45°C was conducted, 
with the storage at each temperature for not less than 48 
hours; and the formulation was examined for stability at 
all these temperatures. The formulation was also 
centrifuged at 3,500 rpm for 30 minutes and examined 
for phase separation. The formulation was subjected to 
four freeze-thaw cycles between -21°C and +25°C and 
observed for phase separation
6
. 
Characterization of the nanoemulsion 
Particle size analysis, polydispersity index (PDI) and 
measurement of surface charge
7 
NE formulations were analyzed for particle size and size 
distribution by Malvern zetasizer. Particle size, size 
distribution and zeta potential were measured by 
dynamic light scattering (DLS). Initially, before 
filtration, higher peaks were found and upon filtration, 
lower peaks were observed. Zeta potential (ζ) 
measurements of the NE formulations were performed 
using Malvern zetasizer. 
Visual characterization: 
The NE was investigated for the presence of structures 
visible to the eye as well as for its texture. 
Assay of phospholipase A2 (PLA2) by indirect 
hemolytic method 
PLA2 activity was carried out by using an indirect 
hemolytic method of Boman HG and Kaletta
8
.Briefly, 
the packed human erythrocytes, egg yolk and phosphate 
buffered saline (1:1:8 V/V) were mixed accordingly. 
1ml of this suspension was incubated separately with 60 
µg of V. russelli venom for 10 min at 37
o
C; the reaction 
was stopped by adding 10 ml of ice-cold phosphate 
buffer saline and centrifuged at 4
o
C for 10 min at 
800×g. The amount of hemoglobin released into the 
supernatant was measured at 540 nm. The assay was 
also carried out in the presence of various concentrations 
2, 4,6, 8 and 10 μg of NE. Lysis of erythrocytes by 
adding 9 ml of distilled water to the control reaction 
mixture was taken as 100%
9
. 
Gastric H
+
/K
+
-ATPase activity 
ATPase activity was determined as described by Im et 
al.
10
. Basal Mg
2+
dependent ATPase activity was 
measured in 1.0 ml of the reaction medium consisting of 
2 mmol/l ATP and 50 mmol/l Tris- HCl buffer (pH 7.5), 
K
+
-stimulated and HCO3
- 
stimulated. ATPase activity 
was defined as the activity in the basal medium. The 
ATPase reaction was started by the addition of the 
substrate (ATP), carried out at 37˚C for 15 minutes and 
stopped with 1.0 ml ice-cold 20% Tri Chloro Acetic 
acid (TCA), liberated inorganic phosphate from ATP 
was estimated by Tsai method
11
. 
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All experiments were repeated in triplicates in three 
independent sets. The assay was also carried out in the 
presence of various concentrations 2, 8 and 10 μg of NE. 
Percent inhibition was calculated by the comparison of 
the inhibition by NE with that of the drug Omeprazole 
(Ome) taken as a standard compound. The concentration 
of test compound causing 50% inhibition (IC50, µg/ml) 
was calculated from the concentration–inhibition 
response curve. 
Anti-oxidant studies 
DPPH radical scavenging assay 
DPPH radical scavenging activity was carried out as 
previously reported by Lingappa Mallesha et al.
12
.  
Briefly, different aliquots of NE; 2, 4, 6 and 8µg was 
mixed with 1 ml of DPPH solution (0.1 mM in 95% 
ethanol) under vigorous shaking.  The mixture was 
allowed to stand for 20 minutes at room temperature and 
following this, absorbance was measured at 517 nm with 
a UV-VIS spectrophotometer (HITACHI, U-2900).  
Radical scavenging potential was expressed as an IC50 
value, i.e., the concentration at which DPPH radicals 
were scavenged up to 50%.  As a positive control for 
DPPH radical scavenging assay, BHT was used. 
Nitric oxide radical scavenging activity 
Griess reaction was used to measure the nitric oxide 
generated from sodium nitroprusside. It has been shown 
that nitric oxide is generated when sodium nitroprusside 
is introduced in phosphate buffer at physiological pH
13
. 
Griess reagent is used to estimate the nitrate ion 
produced by the reaction between nitric oxide and 
oxygen. The nitric oxide radical scavenging activity was 
carried out according to Lingappa Mallesha et al.
12
 with 
slight modifications.  Briefly, reduced production of 
nitric oxide can be seen when the nitric oxide 
scavengers compete with oxygen.  Different aliquots of 
NE; 3,6,9,12 and 15μg was taken and mixed with 
sodium nitroprusside (5mM) in phosphate buffered 
saline and this mixture was incubated at 25°C for 3 
hours.  The absorbance was read against BHT that was 
treated the same way with the Griess reagent at 546 nm 
for the color formed during the diazotization of 
sulphanilamide with nitrite and coupling subsequently 
with naphylethylenediamine. 
Angioinhibitory effect by Shell-less chorioallantoic 
membrane (CAM) assay 
Shell-less chorioallantoic membrane assay is an 
angiogenic assay used for the validation of angio-
inhibitory activity of any given compound. The CAM 
assay, to note the anti-angiogenic activity was 
performed using the NE of Memecylaene. The anti-
angiogenic effect was studied according to the method 
reported by Bushra Begum et al.
14
 with slight 
modifications.  Briefly, surface sterilization of fertilized 
hen’s eggs was done using 70% alcohol.  Fan assisted 
humidified incubator at 37°C was used to incubate the 
eggs.  Within a laminar air flow, 4 day old eggs were 
cracked out into thin films of the hammock and these 
eggs were further incubated.  Proliferating blood vessels 
were seen from the center of the eggs within the 
hammock on the 5
th
 day; later, over these proliferating 
blood vessels, the filter paper discs loaded with 5 µg of 
Memecylaene NE were placed and the eggs were 
incubated again.  Results for the anti-angiogenic effect 
of the molecule were observed after 24 hours of 
incubation.
 
RESULTS AND DISCUSSION 
Table 1: Formulation chart 
Formulation  Oil  Surfactant mix (S mix) 
[Tween 80+Ethanol] 
Water  Surfactant: Co-surfactant 
(Tween 80: Ethanol)  
Oil: S mix  
Memecylaene NE   0.5mg 2ml  7.5 ml 1:1.5  1:4  
 
Stability studies of the nanoemulsion 
After the heating-cooling cycle, centrifugation test and 
freeze-thaw cycle, no phase separation was seen in the 
prepared NE. There were no sediments and hence the 
NE was found to be stable (Fig. 1). 
Characterization of the nanoemulsion 
Particle size analysis, polydispersity index (PDI) and 
measurement of surface charge 
Upon scanning, the size of the blank NE was found to be 
in the range of 11.55nm to 11.65 nm; and that of the 
drug-loaded NE was found to be in the range of 52.02 
nm to 59.47 nm. The PDI of the blank NE was found to 
be 0.400 and that of the drug-loaded NE was found to be 
0.990. Zeta potential of the blank NE was found to be -
1.23 mV and that of the drug-loaded NE was found to be 
-1.27 mV. 
 
Figure 1: The photograph of the Stable 
Memecylaene NE after stability studies 
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Visual characterization 
The formulation had a visually appealing, homogeneous 
appearance which was retained over the observation 
period of two months.  The formulated NE had a 
transparent pale yellow appearance, which in turn fulfils 
its criteria of being an NE. 
Assay of phospholipase A2 by indirect hemolytic 
method 
Inhibition of Russell viper venom PLA2by NE was 
dose-dependent with an IC50 value of 8.92µg/ml 
(Fig.2A). The percentage of PLA2 enzyme that causes 
inflammation inhibition increased with the increased 
concentration of the NE. 
 
 
Gastric (H
+ 
K
+
) ATPase inhibition 
The enzyme was collected from the fundic region of the 
sheep and was stored in the sucrose EDTA buffer. 
ATPase activity in various gastric membranes was 
determined.  The liberated inorganic phosphate from 
ATP was estimated by Tsai method
11
. The NE was 
compared with the standard drug Omeprazole, and the 
NE inhibited (H
+
-K
+
) ATPase to a greater extent 
compared with the standard drug. The inhibition of 
ATPase was dose-dependent (Fig.2B). The NE showed 
an IC50 value of 6.57µg/ml compared to that of the 
reference drug omeprazole with an IC50value of 
9.32µg/ml. 
Anti-oxidant studies 
DPPH radical scavenging assay 
One of the characteristic properties of natural 
antioxidants is their ability to scavenge free radicals. 
DPPH scavenging assay is used to quantify proton-
radical scavenging action of antioxidant. DPPH has 
absorbance maxima of 517 nm. In the presence of an 
antioxidant, the absorbance maxima decrease as 
scavenging of proton-radical take place
15
. Free radical 
scavenging potential is demonstrated by the ability of 
the DPPH molecule to donate hydrogen. NE shows 
DPPH radical scavenging activity due to its hydrogen 
donating capacity. In this work, DPPH radical 
scavenging activity of Memecylaene loaded NE had an 
IC50 value of 5.13µg/ml and comparable with the IC50 
value of 4.36µg/ml for BHT (Fig.3A). DPPH antioxidant 
activity of the NE was compared to the reference 
compound BHT and the NE showed an increased radical 
scavenging activity as the concentration was increased. 
Nitric oxide radical scavenging activity 
NE’s of both Memecylaene and BHT showed a 
significant nitric oxide radical scavenging activity. 
Sodium nitroprusside generated nitric oxide at the 
physiological pH was inhibited by NE of Memecylaene 
with an IC50 value of 3.6µg/ml and BHT with an IC50 
value of 3.84µg/ml. The result reveals that the NE and 
BHT are almost similar in their potency in scavenging 
the nitric oxide radicals (Fig.3B). 
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Angio-inhibitory effect by Shell-less chorioallantoic 
membrane (CAM) assay 
The angio-inhibitory activity of the NE is as shown in 
the (Fig.4A); exhibited significant positive results in the 
shell-less CAM assay model of developing embryos. 
The data shown represent the results using a minimum 
of six eggs in each group. The investigation of anti-
angiogenic activity of NE of Memecylaene (Fig.4B) 
showed a significant reduction of proliferation of 
capillaries around the zone of application of the discs 
loaded with the 5µg of NE. These results indicate that 
the NE forms a   potent anti-angiogenic agent in vivo. 
 
 
Memecylon malabaricum is a potent plant material 
containing a number of bioactive compounds like 
steroids, triterpenes, flavonoids, saponins, tannins and 
resins. The methanolic extract of the plant is reported to 
have anti-microbial activity
16
 and anti-diabetic activity
17
. 
According to the literature, the solubility of 
Memecylaene molecule was difficult due to its 
hydrophobic nature and therefore, an effort was made to 
prepare an NE to increase its solubility and to assess its 
biological activities. 
The results of all these studies suggest that NE is a 
promising novel formulation that can enhance the 
solubility of Memecylaene, comprising of Memecylaene 
and sunflower oil in the oil phase, Tween 80 and ethanol 
in the water phase.  Thus, the nano droplets comprised 
of the hydrophobic molecule ‘Memecylaene', 
surrounded by surfactant and co-surfactant (Smix).  
CONCLUSION 
NE was prepared to increase the solubility of 
Memecylaene, a hydrophobic molecule which was 
isolated from Memecylon malabaricum was found to be 
a potent biologically active molecule which can be used 
as a readily available drug for transdermal delivery. 
Through proper selection of all the critical components 
required for the synthesis of NE, stable drug-loaded NE 
was prepared. 
NE, to date, have been shown to be able to protect labile 
drugs, control its release, increase the bioavailability, 
reduce patient variability and increase drug solubility. 
The results of these studies indicate the potential role of 
O/W type of NE for enhancing the solubility of the 
hydrophobic molecule Memecylaene. The reduction of 
pro-inflammatory biomarkers and an increase in 
antioxidant activity with inhibition of PLA2 shown by 
Memecylaene is a proof for its anti-inflammatory 
activity. We are reporting in our study that NE of 
Memecylaene forms an excellent biocompatible drug 
delivery system comprised of sunflower oil, Tween 80 
and water for the solubilisation of poorly water-soluble 
Memecylaene. The Memecylaene was found to be highly 
solubilized in sunflower oil ranging about 10 mg/ml. 
Further, when incorporated into the oil core of the NE 
system, the drug degradation factor is greatly reduced 
and it maintained a good thermodynamic stability with 
better drug-loading capacity. Moreover, the particle size 
reduction of the drug to nanometres range would 
significantly improve the dissolution rate and thereby 
improve the bioavailability of the molecule in in-vivo 
after administration. Thus, the therapeutic efficacy of the 
drug would be enhanced to meet the patient’s need. 
Also, the development of NE formulation of 
Memecylaene with optical clarity and low-viscosity 
involving no high-energy methods would be of interest 
to pharmaceutical scientists. 
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